Page 10 - Gene Therapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aziyo Biologics (NASDAQ:AZYO – Get Rating) and Passage Bio (NASDAQ:PASG – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Profitability This table compares Aziyo Biologics and Passage Bio’s […]

PHILADELPHIA, April 21, 2023 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced... | April 21, 2023

The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, has completed a successful...

A novel coronavirus would come to affect every ward, clinician, researcher and patient at Massachusetts General Hospital.

PHILADELPHIA, March 27, 2023 -- Passage Bio, Inc. , a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced... | March 27, 2023